Scilex 与机构投资者签署证券购买协议

Core Insights - Scilex Holding Company has signed an agreement with an institutional investor to exchange its shares in Semnur Pharmaceuticals, valued at approximately $200 million, for an equivalent amount in Bitcoin [1] - The transaction involves 12.5 million shares at a price of $16 per share [1] - Scilex is also collaborating with the cryptocurrency platform Biconomy to advance its cryptocurrency reserves and financial management strategy [1]